[ET Net News Agency, 26 August 2020] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said its profit attributable to owners of the parent was RMB1.71 billion for the
six months ended 30 June 2020, a year-on-year increase of 13.1%. The earnings per share
were RMB0.67. No dividend will be distributed.
The revenue was RMB13.97 billion, a year-on-year decrease of 0.85%. (RC)